cgmp deviation

AsiaMap2

Asia

FiercePharmaAsia: PRA and Takeda’s Japan JV, Sun, ASLAN and more

PRA and Takeda are building a Japan JV, Sun's quarterly profits dropped, ASLAN posted positive top-line phase 2 data for varlitinib.

Angus Liu Feb 17, 2017 9:31am

cosmetics bottles

China facility of Ausmetics hit with FDA warning letter

Feb 15, 2017 2:51pm